These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11889847)

  • 1. Colorectal cancer screening among individuals with and without a family history.
    Thrasher JF; Cummings KM; Michalek AM; Mahoney MC; Moysich KB; Pillittere DM
    J Public Health Manag Pract; 2002 Mar; 8(2):1-9. PubMed ID: 11889847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers.
    Mack LA; Cook LS; Temple WJ; Carlson LE; Hilsden RJ; Paolucci EO
    Ann Surg Oncol; 2009 Aug; 16(8):2092-100. PubMed ID: 19479307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of colorectal cancer screening in a large medical organization.
    Hawley ST; Vernon SW; Levin B; Vallejo B
    Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):314-9. PubMed ID: 14973108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of self-reported colorectal cancer (CRC) screening in a study of ethnically diverse first-degree relatives of CRC cases.
    Bastani R; Glenn BA; Maxwell AE; Ganz PA; Mojica CM; Chang LC
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):791-8. PubMed ID: 18381469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China].
    Chen HD; Li N; Ren JS; Shi JF; Zhang YM; Zou SM; Zheng ZX; Zhang K; Dai M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):231-237. PubMed ID: 29973000
    [No Abstract]   [Full Text] [Related]  

  • 7. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment.
    Jones RM; Mongin SJ; Lazovich D; Church TR; Yeazel MW
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):777-84. PubMed ID: 18381476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated with Colorectal Cancer Screening among Mississippi Adults: Findings from the Behavioral Risk Factor Surveillance System.
    Zhang WQ; Tang SJ; Dobbs TE; Zhang L
    South Med J; 2020 Jul; 113(7):360-365. PubMed ID: 32617599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
    Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining local colorectal cancer screening utilization patterns.
    Cibula DA; Morrow CB
    J Public Health Manag Pract; 2003; 9(4):315-21. PubMed ID: 12836514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial colorectal cancer screening: When and what to do?
    Del Vecchio Blanco G; Paoluzi OA; Sileri P; Rossi P; Sica G; Pallone F
    World J Gastroenterol; 2015 Jul; 21(26):7944-53. PubMed ID: 26185367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening: Early alert.
    Willyard C
    Nature; 2015 May; 521(7551):S4-5. PubMed ID: 25970456
    [No Abstract]   [Full Text] [Related]  

  • 13. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy.
    Federici A; Marinacci C; Mangia M; Borgia P; Giorgi Rossi P; Guasticchi G
    Cancer Detect Prev; 2006; 30(4):347-53. PubMed ID: 16965874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?
    Seeff LC; Manninen DL; Dong FB; Chattopadhyay SK; Nadel MR; Tangka FK; Molinari NA
    Gastroenterology; 2004 Dec; 127(6):1661-9. PubMed ID: 15578502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal adherence with fecal occult blood test screening in community practice.
    Fenton JJ; Elmore JG; Buist DS; Reid RJ; Tancredi DJ; Baldwin LM
    Ann Fam Med; 2010; 8(5):397-401. PubMed ID: 20843880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer screening in Canada: results of a national survey.
    Sewitch MJ; Fournier C; Ciampi A; Dyachenko A
    Chronic Dis Can; 2008; 29(1):9-21. PubMed ID: 19036219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to national guidelines for colorectal cancer screening in Israel: Comprehensive multi-year assessment based on electronic medical records.
    Paltiel O; Keidar Tirosh A; Paz Stostky O; Calderon-Margalit R; Cohen AD; Elran E; Valinsky L; Matz E; Krieger M; Yehuda AB; Jaffe DH; Manor O
    J Med Screen; 2021 Mar; 28(1):25-33. PubMed ID: 32356670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of colorectal cancer screening: a comparison of men and women.
    McGregor SE; Bryant HE
    Can J Gastroenterol; 2005 Jun; 19(6):343-9. PubMed ID: 15997267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.